TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF GLOBAL VENTILATOR MARKET 22
1.4 CURRENCY AND PRICING 23
1.5 LIMITATION 23
1.6 MARKETS COVERED 23
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GEOGRAPHIC SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 RESEARCH METHODOLOGY 28
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.7 DBMR MARKET CHALLENGE MATRIX 32
2.8 SECONDARY SOURCES 33
2.9 ASSUMPTIONS 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 37
5 MARKET OVERVIEW 40
5.1 DRIVERS 42
5.1.1 INCREASING NUMBER OF CHRONIC DISEASES 42
5.1.2 RISING NUMBER OF ICU BEDS 42
5.1.3 RISING NUMBER OF PRETERM BIRTH AND EMERGING TECHNOLOGIES OF NEONATAL CARE 43
5.1.4 ADVANCEMENT IN TECHNOLOGIES 45
5.2 RESTRAINTS 46
5.2.1 HIGH COST OF EQUIPMENT 46
5.2.2 PRODUCTS RECALL 47
5.3 OPPORTUNITIES 47
5.3.1 DEMAND FOR COST-SAVING TECHNOLOGIES 47
5.4 CHALLENGES 48
5.4.1 RISK ASSOCIATED WITH THE MECHANICAL VENTILATION 48
?
6 GLOBAL VENTILATOR MARKET, BY PRODUCT TYPE 49
6.1 OVERVIEW 50
6.2 INTENSIVE CARE VENTILATORS 52
6.2.1 HIGH-END ICU VENTILATORS 53
6.2.2 BASIC ICU VENTILATORS 53
6.2.3 MID-END ICU VENTILATORS 53
6.3 PORTABLE VENTILATORS 53
6.4 NEONATAL VENTILATORS 54
7 GLOBAL VENTILATOR MARKET, BY MODALITY 55
7.1 OVERVIEW 56
7.2 NON-INVASIVE VENTILATION 58
7.2.1 VOLUME-CYCLED VENTILATORS 59
7.2.2 PRESSURE-CYCLED VENTILATORS 59
7.2.3 CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATORS 59
7.2.4 BI-LEVEL POSITIVE AIRWAY PRESSURE VENTILATORS 59
7.2.5 FLOW-CYCLED VENTILAATORS 59
7.2.6 TIME-CYCLED VENTILATORS 59
7.3 INVASIVE VENTILATION 60
8 GLOBAL VENTILATOR MARKET, BY TYPE 61
8.1 OVERVIEW 62
8.2 ADULT VENTILATORS 63
8.3 NEONATAL VENTILATORS 64
8.4 PEDIATRIC VENTILATORS 64
9 GLOBAL VENTILATOR MARKET, BY MODE 65
9.1 OVERVIEW 66
9.2 COMBINED-MODE VENTILATION 67
9.3 VOLUME-MODE VENTILATION 68
9.4 PRESSURE-MODE VENTILATOR 68
9.5 OTHER 69
10 GLOBAL VENTILATOR MARKET, BY END USER 70
10.1 OVERVIEW 71
10.2 HOSPITALS 72
10.3 AMBULATORY SURGERY CENTRES 73
10.4 SPECIALTY CLINICS 73
10.5 LONG TERM CARE CENTRES 74
10.6 REHABILITATION CENTRES 74
10.7 HOMECARE SETTINGS 75
11 GLOBAL VENTILATOR MARKET, BY GEOGRAPHY 76
11.1 OVERVIEW 77
11.2 NORTH AMERICA 82
11.2.1 U.S. 88
11.2.2 CANADA 91
11.2.3 MEXICO 94
11.3 EUROPE 97
11.3.1 GERMANY 104
11.3.2 U.K. 107
11.3.3 FRANCE 110
11.3.4 SPAIN 113
11.3.5 ITALY 116
11.3.6 SWITZERLAND 119
11.3.7 NETHERLANDS 122
11.3.8 BELGIUM 125
11.3.9 RUSSIA 128
11.3.10 TURKEY 131
11.3.11 REST OF EUROPE 134
11.4 ASIA-PACIFIC 135
11.4.1 JAPAN 141
11.4.2 CHINA 144
11.4.3 INDIA 147
11.4.4 SOUTH KOREA 150
11.4.5 AUSTRALIA 153
11.4.6 SINGAPORE 156
11.4.7 THAILAND 159
11.4.8 MALAYSIA 162
11.4.9 INDONESIA 165
11.4.10 PHILIPPINES 168
11.4.11 REST OF ASIA-PACIFIC 171
11.5 SOUTH AMERICA 172
11.5.1 BRAZIL 178
11.5.2 REST OF SOUTH AMERICA 181
11.6 MIDDLE EAST & AFRICA 182
11.6.1 SOUTH AFRICA 188
11.6.2 REST OF MIDDLE EAST & AFRICA 191
12 GLOBAL VENTILATOR MARKET, COMPANY LANDSCAPE 192
12.1 COMPANY SHARE ANALYSIS; GLOBAL 192
12.2 COMPANY SHARE ANALYSIS; NORTH AMERICA 193
12.3 COMPANY SHARE ANALYSIS; EUROPE 194
12.4 COMPANY SHARE ANALYSIS; ASIA-PACIFIC 195
13 COMPANY PROFILES 196
13.1 KONINKLIJKE PHILIPS N.V. 196
13.1.1 COMPANY SNAPSHOT 196
13.1.2 REVENUE ANALYSIS 196
13.1.3 COMPANY SHARE ANALYSIS 197
13.1.4 PRODUCT PORTFOLIO 197
13.1.5 RECENT DEVELOPMENT 198
13.2 MEDTRONIC 199
13.2.1 COMPANY OVERVIEW 199
13.2.2 REVENUE ANALYSIS 199
13.2.3 COMPANY SHARE ANALYSIS 200
13.2.4 PRODUCT PORTFOLIO 200
13.2.5 RECENT DEVELOPMENTS 201
13.3 GE HEALTHCARE 202
13.3.1 COMPANY OVERVIEW 202
13.3.2 REVENUE ANALYSIS 202
13.3.3 COMPANY SHARE ANALYSIS 203
13.3.4 PRODUCT PORTFOLIO 203
13.3.5 RECENT DEVELOPMENTS 203
13.4 DRaGERWERK AG & CO. KGAA, 204
13.4.1 COMPANY OVERVIEW 204
13.4.2 REVENUE ANALYSIS 204
13.4.3 COMPANY SHARE ANALYSIS 205
13.4.4 PRODUCT PORTFOLIO 205
13.4.5 RECENT DEVELOPMENTS 206
13.5 ACUTRONIC MEDICAL SYSTEMS AG 207
13.5.1 COMPANY OVERVIEW 207
13.5.2 GEOGRAPHIC PRESENCE 207
13.5.3 PRODUCT PORTFOLIO 208
13.5.4 RECENT DEVELOPMENTS 208
13.6 AIR LIQUIDE 209
13.6.1 COMPANY OVERVIEW 209
13.6.2 REVENUE ANALYSIS 209
13.6.3 PRODUCT PORTFOLIO 210
13.6.4 RECENT DEVELOPMENT 211
?
13.7 ALLIED HEALTHCARE PRODUCTS, INC. 212
13.7.1 COMPANY OVERVIEW 212
13.7.2 REVENUE ANALYSIS 212
13.7.3 PRODUCT PORTFOLIO 213
13.7.4 RECENT DEVELOPMENTS 213
13.8 BUNNELL INCORPORATED 214
13.8.1 COMPANY OVERVIEW 214
13.8.2 PRODUCT PORTFOLIO 214
13.8.3 RECENT DEVELOPMENTS 214
13.9 FISHER & PAYKEL HEALTHCARE LIMITED 215
13.9.1 COMPANY OVERVIEW 215
13.9.2 REVENUE ANALYSIS 215
13.9.3 PRODUCT PORTFOLIO 216
13.9.4 RECENT DEVELOPMENTS 216
13.10 GETINGE AB 217
13.10.1 COMPANY OVERVIEW 217
13.10.2 REVENUE ANALYSIS 217
13.10.3 PRODUCT PORTFOLIO 218
13.10.4 RECENT DEVELOPMENTS 218
13.11 HAMILTON MEDICAL 219
13.11.1 COMPANY OVERVIEW 219
13.11.2 GEOGRAPHIC PRESENCE 219
13.11.3 PRODUCT PORTFOLIO 220
13.11.4 RECENT DEVELOPMENTS 221
13.12 LEISTUNG EQUIPAMENTOS LTDA. 222
13.12.1 COMPANY OVERVIEW 222
13.12.2 PRODUCT PORTFOLIO 222
13.12.3 RECENT DEVELOPMENTS 222
13.13 MAGNAMED 223
13.13.1 COMPANY OVERVIEW 223
13.13.2 PRODUCT PORTFOLIO 223
13.13.3 RECENT DEVELOPMENTS 224
13.14 PENLON LIMITED 225
13.14.1 COMPANY OVERVIEW 225
13.14.2 PRODUCT PORTFOLIO 225
13.14.3 RECENT DEVELOPMENTS 225
13.15 RESMED 226
13.15.1 COMPANY OVERVIEW 226
13.15.2 REVENUE ANALYSIS 226
13.15.3 PRODUCT PORTFOLIO 227
13.15.4 RECENT DEVELOPMENTS 228
13.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 229
13.16.1 COMPANY OVERVIEW 229
13.16.2 GEOGRAPHIC PRESENCE 229
13.16.3 PRODUCT PORTFOLIO 230
13.16.4 RECENT DEVELOPMENTS 230
13.17 SMITHS GROUP PLC 231
13.17.1 COMPANY OVERVIEW 231
13.17.2 REVENUE ANALYSIS 231
13.17.3 PRODUCT PORTFOLIO 232
13.17.4 RECENT DEVELOPMENTS 232
13.18 VYAIRE MEDICAL INC. 233
13.18.1 COMPANY SNAPSHOT 233
13.18.2 GEOGRAPHICAL PRESENCE 233
13.18.3 PRODUCT PORTFOLIO 234
13.18.4 RECENT DEVELOPMENTS 236
13.19 ZOLL MEDICAL CORPORATION 237
13.19.1 COMPANY OVERVIEW 237
13.19.2 GEOGRAPHIC PRESENCE 237
13.19.3 PRODUCT PORTFOLIO 238
13.19.4 RECENT DEVELOPMENT 238
14 RELATED REPORTS 239